ventricular apex, right ventricular outflow tract (RVOT) or left ventricle. Sustained polymorphic ventricular tachycardia was defined as arrhythmia lasting longer than 30 ms or requiring termination because of hemodynamic collapse. The protocol of ventricular stimuli included up to 3 extrastimuli (2 basic cycle lengths of 600 and 400 ms) and rapid ventricular pacing, with the coupling interval of the extrastimuli being not less than 180 ms and the ventricular rate of rapid burst pacing not exceeding 270 beats/min.
Results

Characteristics of Patients in Group A
The clinical and electrocardiographic characteristics of the patients in group A are summarized in In group B, recording the ECG in the 4th ICS revealed a Brugada-type ECG in 3 (1.5%) of the 206 subjects ( Table 2 ), The type 1 ECG was found in 1 of those 3 and he also had a type 1 ECG when the ECG was recorded in the 3rd ICS (Fig 1A) . The other 2 subjects had a type 3 ECG and they showed conversion to the type 2 ECG when the ECG was recorded in the 3rd ICS (Fig 1B) . When the ECG was recorded in the 3rd ICS, a Brugada-type ECG was found in 12 (5.8%) of the 206 subjects, one of whom showed conversion of a normal ECG to a type 1 ECG (Fig 1C) .
Discussion
Brugada et al reported that induction of VA during an EPS is a predictor of the occurrence of arrhythmia in patients with a Brugada-type ECG and they recommended ICD implantation for such patients. 4 Wilde et al have recently proposed 3 types of repolarization pattern in Brugada-type ECGs as the criteria for diagnosis of Brugada syndrome. 21 They report that there is a high risk of cardiac sudden death in patients with type 1 ECG and that a drug challenge test is recommended for clarifying the diagnosis in patients with type 2 or type 3 ECGs; conversion of a type 2 or type 3 ECG to type 1 ECG by the test is considered positive. The ECG recorded with leads V1 and V2 in the 3rd ICS are considered to reflect the potentials of the RVOT and are thought to be useful for detecting the Brugada sign. [17] [18] [19] In the present study, the type 1 ECG was found in 4 (23.5%) of the 17 patients in group A when the ECG was recorded in the 4th ICS and all 4 patients had VA induced during the EPS Another 6 patients who had VA induced in the EPS had a type 2 or type 3 ECG and of these, 5 showed conversion to a type 1 ECG when the ECG was recorded in the 3rd ICS. These results indicate that both the type 1 ECG and conversion to the type 1 ECG are related to induction of VA and suggest that patients at high risk for cardiac sudden death might be identified by recording the ECG in the 3rd ICS, even if a drug test has not been performed.
Group checkups are frequently performed in Japan and a Brugada-type ECG is often found. The incidence of Brugada syndrome is higher in Asian countries than elsewhere and the average prevalence of Brugada-type ECGs in Japan is 0.27% (range: 0.14-0.7%). 6, [23] [24] [25] [26] In the present study, the prevalence of a Brugada-type ECG recorded in the 4th ICS was 1.5%, which is higher than in other reports. However, Miyasaka et al reported that the prevalence of Brugada-type ECG was 2.14% in male subjects only and that the presentation of a Brugada-type ECG was not uncommon. 25 The prevalence of type 1 and type 2 ECGs, which are typical Brugada-type ECGs, was 0.49% in the present study, which is similar to the prevalence reported in other populations. The prevalence of Brugada-type ECGs increased from 1.5% to 5.8% when the ECG was recorded in the 3rd ICS; one patient even showed conversion of a normal ECG to a type 1 ECG. These findings suggest that recording ECG in the 3rd ICS might be a useful screening method for identifying high-risk patients with a Brugada-type ECG, but such patients would still require Ic drug tests and an EPS during the follow-up period after the diagnosis of Brugada syndrome.
A major limitation of the present study is the small number of patients and thus a further prospective study and more evaluation are needed.
Conclusions
The findings from the present study suggest that recording the ECG in the 3rd ICS might be a useful methods of screening for identifying high-risk patients with a Brugadatype ECG and for detecting the concealed Brugada-type ECG.
